A Phase 3 study of Pimecrolimus Ophthalmic Ointment in Blepharitis

Study Description

A Study to Evaluate the Effectiveness and Safety of Pimecrolimus 0.3% Eye Ointment in Treating Blepharitis

Study Details

Registry ID:

NCT06400511

Conditions:

Blepharitis

Phase:

Phase 3

Target Enrollment:

477 participants

Start Date:

April 22, 2024

Age Range:

2–999 years

Healthy Volunteers:

No

Study Locations (31 sites)

• Clinical Investigative Site
  Pheonix, ArizonaUnited States, United States
• Clinical Investigator Site
  Havre De Grace, MarylandUnited States, United States
• Clinical Investigator Site
  Garner, North CarolinaUnited States, United States
• Clinical Investigator Site
  Tampa, FloridaUnited States, United States
• Clinical Investigator Site
  Largo, FloridaUnited States, United States
• Clinical Investigator Site
  Crystal River, FloridaUnited States, United States
• Clinical Investigator Site
  Lynchburg, VirginiaUnited States, United States
• Clinical Investigator Site
  Cranberry Township, PennsylvaniaUnited States, United States
• Clinical Investigator Site
  Morrow, GeorgiaUnited States, United States
• Clinical Investigator Site
  Atlanta, GeorgiaUnited States, United States
• Clinical Investigator Site
  Cincinnati, OhioUnited States, United States
• Clinical Investigator Site
  Smyrna, TennesseeUnited States, United States
• Clinical Investigator Site
  Louisville, KentuckyUnited States, United States
• Investigative Site
  Saint Louis, MissouriUnited States, United States
• Investigative Site
  St Louis, MissouriUnited States, United States
• Clinical Investigator Site
  Washington, MissouriUnited States, United States
• Clinical Investigator Site
  Pittsburg, KansasUnited States, United States
• Clinical Investigator Site
  Austin, TexasUnited States, United States
• Clinical Investigator Site
  Kansas City, MissouriUnited States, United States
• Clinical Investigator Site
  Lakeway, TexasUnited States, United States
• Clinical Investigator Site
  San Antonio, TexasUnited States, United States
• Clinical Investigator Site
  Medina, MinnesotaUnited States, United States
• Clinical Investigator Site
  Aurora, ColoradoUnited States, United States
• Clinical Investigative Site
  Phoenix, ArizonaUnited States, United States
• Clinical Investigator Site
  Clinton, UtahUnited States, United States
• Clinical Investigator Site
  Newport Beach, CaliforniaUnited States, United States
• Clinical Investigator Site
  Garden Grove, CaliforniaUnited States, United States
• Clinical Investigator Site
  Glendale, CaliforniaUnited States, United States
• Clinical Investigator Site
  Inglewood, CaliforniaUnited States, United States
• Clinical Investigator Site
  Rancho Cordova, CaliforniaUnited States, United States
• Clinical Investigator Site
  Petaluma, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →